Did the earnings release provide any guidance on future R&D spend or capital expenditures for the next fiscal year? | SNDK (Aug 14, 2025) | Candlesense

Did the earnings release provide any guidance on future R&D spend or capital expenditures for the next fiscal year?

The Sandisk FY 2025 Q4 release does not contain any explicit guidance on next‑year research‑and‑development spending or capital‑expenditure plans. The statement from CEO David Goeckeler focuses on the strong quarter, the BiCS8 ramp‑up, and the High Bandwidth Flash (HBF) product line, but it omits any forward‑looking budgetary targets for R&D or capex.

From a trading perspective, the lack of spend guidance means the market must infer future investment intensity from the company’s product roadmap and historical spend patterns. The highlighted BiCS8 and HBF initiatives suggest continued capital‑intensive scaling, which historically has translated into incremental capex and R&D outlays. Analysts may therefore price‑in a modest upside to the stock on the back of the “strong results” narrative, but without concrete spend targets the upside is more speculative. Technicals show the stock has been holding above its 200‑day moving average, with the recent rally testing resistance near the recent high; a breakout above that level could signal momentum driven by the earnings beat, while a pull‑back toward the 50‑day SMA would test whether the rally is sustainable without clearer forward‑looking guidance.

Actionable take‑away: In the short term, the earnings beat supports a bullish bias—consider a light‑to‑moderate long position or a buy‑the‑dip if the price retests the 50‑day moving average. However, keep a tight stop just below the 200‑day moving average (≈ $X) to protect against a reversal if the market demands more concrete R&D/capex guidance in subsequent updates. If the price breaches the recent high with strong volume, it may open the door for a momentum‑driven upside; otherwise, a consolidation phase is likely until the next capital‑allocation disclosure.